A study by Ulla Sovio, Gordon Smith and colleagues, published in Nature Medicine, has identified metabolites predictive of fetal growth restriction (FGR) at term.
The study was funded by NIHR Cambridge Biomedical Research Centre (Women’s Health theme), Medical Research Council, Wellcome Trust, National Institutes of Health, European Research Council and NIHR Bristol Biomedical Research Centre.
Access the full article